EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren's syndrome

Rheumatology International

Volumn 28, Issue 2, 2007, Pages 127-136

  Nakamura, Hideki ^a   Kawakami, Atsushi ^a   Ida, Hiroaki ^a   Koji, Takehiko ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Akt; Epidermal growth factor; NF B; Salivary epithelial cells; Sj gren's syndrome

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SYNAPTOTAGMIN I; WORTMANNIN;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SALIVARY GLAND; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BIOPSY; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; RHODAMINES; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 36148937149     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0411-9     Document Type: Article

References (33)

1. Fox RI, Stern M, Michelson P (2000) Update in Sjögren's syndrome. Curr Opin Rheumtol 12:391-398
2. Kong L, Ogawa N, Nakabayashi T, Liu GT, D'Souza E, McGuff HS et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40:87-97
3. Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y et al (1998) Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol 114:106-112
4. Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG (2004) Fas gene promoter polymorphisms in primary Sjögren's syndrome. Ann Rheum Dis 63:98-101
5. Jonsson R, Gordon TP, Konttinen YT (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome. Curr Rheumatol Rep 5:311-316
6. Ohlsson M, Szodoray P, Loro LL, Johannessen AC, Jonsson R (2002) CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases. Scand J Immunol 56:561-571
7. Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM (1998) Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin Exp Immunol 114:485-490
8. Yamamura Y, Onodera K, Ichinohasama R, Ooya K (2000) A histopathological study of lymphoepithelial island formation in labial salivary glands in patients with primary Sjögren's syndrome. J Oral Pathol Med 29:110-117
9. Gorgoulis V, Giatromanolaki A, Iliopoulos A, Kanavaros P, Aninos D, Ioakeimidis D et al (1993) EGF and EGF-R immunoexpression in Sjögren's syndrome secondary to rheumatoid arthritis. Correlation with EBV expression? Clin Exp Rheumatol 11:623-627
10. Anest V, Cogswell PC, Baldwin AS Jr (2004) IkappaB kinase alpha and p65/RelA contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IkappaBalpha degradation. J Biol Chem 279:31183-31189
11. Kitagawa K, Hamada Y, Kato Y, Nakai K, Nishizawa M, Ito S et al (2004) Epidermal growth factor and interleukin-1beta synergistically stimulate the production of nitric oxide in rat intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 287:G1188-G1193
12. Dhar A, Young MR, Colburn NH (2002) The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235:185-193
13. Navolanic PM, Steelman LS, McCubrey JA (2003) EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 22:237-252
14. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22:8983-8998
15. Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43-52
16. Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86-90
17. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q et al (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279:1615-1620
18. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554-558
19. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S (2002) Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma- inducible 10 kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 46:2730-2741
20. Ping L, Ogawa N, Sugai S (2005) Novel role of CD40 in fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome. Arthritis Rheum 52:573-581
21. Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A et al (1997) High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56:167-172
22. Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T et al (1999) Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome. Lab Invest 79:261-269
23. Matsumura R, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M et al (1996) Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome. Clin Exp Rheumatol 14:309-311
24. Ahn JY, Rong R, Liu X, Ye K (2004) PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J 23:3995-4006
25. Keates S, Keates AC, Katchar K, Peek RM Jr, Kelly CP (2007) Helicobacter pylori Induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 196:95-103
26. Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K (1999) Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren's syndrome. Ann Rheum Dis. 58:382-385
27. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85
28. Dhawan P, Singh AB, Ellis DL, Richmond A (2002) Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res 62:7335-7442
29. Kao SJ, Lei HC, Kuo CT, Chang MS, Chen BC, Chang YC et al (2005) Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 115:366-374
30. Meng F, Liu L, Chin PC, D'Mello SR (2002) Akt is a downstream target of NF-kappa B. J Biol Chem 277:29674-29680
31. Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ (2003) Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. J Biol Chem 278:45737-45745
32. Ackland ML, Newgreen DF, Fridman M, Waltham MC, Arvanitis A, Minichiello J et al (2003) Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83:435-448
33. Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K. Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with Sjögren's syndrome accepted in Clin Exp Rheumatol